Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Drugs acting on the blood and blood forming organs
Ferric derisomaltose
Другие языки:

    Ferric derisomaltose

    Подписчиков: 0, рейтинг: 0

    Ferric derisomaltose
    Clinical data
    Trade names Monoferric, Monofer
    AHFS/Drugs.com Monograph
    License data
    Routes of
    administration    		 Intravenous (IV)
    ATC code
    • None
    Legal status
    Legal status
    Identifiers
    • iron(3+);(2S,3R,4R,5R)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxyhexane-1,2,3,4,5-pentol
    CAS Number
    PubChem CID
    DrugBank
    UNII
    KEGG
    Chemical and physical data
    Formula C18H34FeO16+3
    Molar mass 562.299 g·mol−1
    3D model (JSmol)
    • C(C1C(C(C(C(O1)OCC2C(C(C(C(O2)OCC(C(C(C(CO)O)O)O)O)O)O)O)O)O)O)O.[Fe+3]
    • InChI=1S/C18H34O16.Fe/c19-1-5(21)9(23)10(24)6(22)3-31-17-16(30)14(28)12(26)8(34-17)4-32-18-15(29)13(27)11(25)7(2-20)33-18;/h5-30H,1-4H2;/q;+3/t5-,6+,7+,8+,9+,10+,11+,12+,13-,14-,15+,16+,17-,18-;/m0./s1
    • Key:JTQTXQSGPZRXJF-DOJSGGEQSA-N

    Ferric derisomaltose, sold under the brand name Monoferric among others, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease (NDD-CKD). It was approved for use in the United States in January 2020. It is given intravenously.

    External links



    Новое сообщение